Biodegradable Cisplatin Microspheres for Direct Brain Injection: Preparation and Characterization

References

• Evans R. G. The role of radiation therapy in the treatment of adult brain tumors. Brain Tumors: A Comprehensive Text, R. A. Morantz, J. W. Walsh. Marcel Dekker, New York 1994; 643–657
   Google Scholar
• The Johns Hopkins Medical Handbook: The 100 Major Medical Disorders of People over the Age of 50. Random House, New York 1992; 131–136, Prepared by the editors of the Jonhs Hopkins medical letter health after 50. Rebus
   Google Scholar
• Chasin M., Hollenbeck G., Brem H., Grossman S., Colvin M., Langer R. Interstitial drug therapy for brain tumors: A case study. Drug. Dev. Ind. Pharm 1990; 16(18)2579–2594
   Web of Science ®Google Scholar
• Brem H., Mahaley M. S., Vick N. A., Black K. L., Schold S. C., Burger P. C., Friedman A. H., Ciric I. S., Eller T. W., Cozzens J. W., Kenealy J. N. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg 1991; 74(3)441–446
   PubMed Web of Science ®Google Scholar
• Grossman S. A., Reinhard C., Colvin M., Chasin M., Brundrett R., Tamargo R. J., Brem H. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J. Neurosurg 1992; 76(4)640–647
   PubMed Web of Science ®Google Scholar
• Tamargo R. J., Myseros J. S., Epstein J. I., Yang M. B., Chasin M., Brem H. Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain. Cancer Res 1993; 53(1)329–333
   PubMedGoogle Scholar
• Wu M. P., Tamada J. A., Brem H., Langer R. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. J. Biomed. Mat. Res 1994; 28(3)387–395
   PubMedGoogle Scholar
• Boisdron-Celle M., Menei P., Benoit J. P. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. J. Pharm. Pharmacol 1995; 47: 108–114
   PubMed Web of Science ®Google Scholar
• Menei P., Croué A., Pouplard-Barthelaix A., Benoit J. P. Fate and biocompatibility of three types of microspheres implanted into the brain. J. Biomed. Mat. Res 1994; 28: 1079–1085
   PubMed Web of Science ®Google Scholar
• Menei P., Benoit J. P., Boisdron-Celle M., Fournier D., Mercier P., Guy G. Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. Neurosurgery 1994; 34(6)1058–1063
   PubMed Web of Science ®Google Scholar
• Calabresi P., Parks R. E. Chemotherapy of neoplastic diseases. The Pharmacological Basis of Therapeutics, A. Goodman Gilman, L. S. Goodman. Macmillan Publishing Co., New York 1985; 1290–1291
   Google Scholar
• Shapiro W. R. Chemotherapy of malignant gliomas: Studies of the BTCG. Rev. Neurol. Paris 1992; 148: 428–434
   PubMedGoogle Scholar
• Rogers L. R., Purvis J. B., Lederman R. J., Rosenbloom S. A., Tomsak R. L., Estes M. L., Magdinec M., Medendorp S. V., Boyett J. M. Alternating sequential intracarotid BCNU and cisplatin in recurrent malignant glioma. Cancer 1991; 68(1)15–21
   PubMedGoogle Scholar
• Kyritsis A. P. Chemotherapy for malignant gliomas. Oncology 1993; 7(9)93–100
   PubMedGoogle Scholar
• Menei P., Daniel V., Montero-Menei C., Brouillard M., Puoplard-Barthelaix A., Benoit J. P. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials 1993; 14(6)470–478
   PubMed Web of Science ®Google Scholar
• Watts P. J., Davies M. C., Melia C. D. Microencapsulation using emulsification/solvent evaporation: An overview of techniques and applications. Crit. Rev. Ther. Drug Carrier Syst 1990; 7(3)235–259
   PubMed Web of Science ®Google Scholar
• Andrews R. J., Bringas J. R., Alonzo G. Cerebrospinal fluid pH and Pco2 rapidly follow arterial blood pH and Pco2 with changes in ventillation. Neurosurgery 1994; 34(3)466–470
   PubMedGoogle Scholar
• Dewaal W. A. J. F., Maessen J. M. J., Kraak J. C. Analytical methodologies for the quantitation of platinum anti-cancer drugs and related compounds in biological media. J. Pharm. Biomed. Anal 1990; 8(1): 1–30
   Google Scholar
• Li C., Yang D. J., Nikiforow S., Tansey W., Kuang L. R., Wright K. C., Wallace S. Formation and characterization of cisplatin loaded poly(benzyl-L-glutamate) microspheres for chemoembolization. Pharm. Res 1994; 11(12)1792–1799
   PubMedGoogle Scholar
• Jalil R., Nixon J. R. Microencapsulation using poly(L-lactic acid). II. Preparative variables affecting microcapsule properties. J. Microencap 1990; 7(1)25–39
   PubMed Web of Science ®Google Scholar
• Cavalier M., Benoit J. P., Thies C. The formation and characterization of hydrocortisone-loaded poly-(±lactide) microspheres. J. Pharm. Pharmacol 1986; 38(4)249–253
   PubMedGoogle Scholar
• Jalil R., Nixon J. R. Microencapsulation using poly(L-lactic acid). III. Effect of polymer molecular weight on the microcapsule properties. J. Microencap 1990; 7(1)41–52
   PubMed Web of Science ®Google Scholar
• Saini P., Greenspan P., Lu D. R. Adsorption of brain proteins on the surface of poly (D,L lactide-co-glycolide (PLGA) microspheres. Pharm. Res, submitted for publication
   Google Scholar
• Abu-Izza K., Lu D. R. Effect of gastrointestinal protein adsorption on the in vitro release of AZT from ethylcellulose microspheres, unpublished data, manuscript in preparation
   Google Scholar
• Tsai T., Mehta R., DeLuca P. Adsorption of peptides to poly(D,L-lactide-co-glycolide). I. Effect of physical factors on the adsorption. Int. J. Pharm 1996; 127: 31–42
   Web of Science ®Google Scholar
• Fitzgerald J. F., Corrigan O. I. Mechanisms governing drug release from poly-α-hydroxy aliphatic esters. Dialtiazem base release from poly(lactide-co-glycolide) delivery systems. Polymeric Delivery Systems. Properties and Applications, M. A. El-Nokaly, D. M. Piatt, B. A. Charpentier. American Chemical Society. 1993; 311–326
   Google Scholar
• Nakano M., Wakiyama N., Kojima T., Juni K., Inoue S. Biodegradable microspheres for prolonged local anesthesia. Microspheres and Drug Therapy, S. S. Davis, L. Ilium, J. G. McVie, E. Tomlinson. Elsevier Science Publishers, AmsterdamThe Netherlands 1984; 327–335
   Google Scholar
• Juni K., Nakano M. Poly(lactic acid) microspheres as drug carrier systems. Polymers in Controlled Drug Delivery, L. Ilium, S. S. Davis. Bath Press, BathUK 1987; 49–59
   Google Scholar
• Ogawa Y., Okada H., Yamamoto M., Shimamoto T. In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acid or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. Chem. Pharm. Bull 1988; 36(7)2576–2581
   PubMed Web of Science ®Google Scholar
• Wood D. A. Biodegradable drug delivery systems. Int. J. Pharm 1980; 7(3)1–18
   Google Scholar
• Pitt C. G., Gratzl M. M., Kimmel G. L., Surles J., Schindler A. Aliphatic polyesters. II. The degradation of poly(D,L-lactide), poly(ϵ-caprolactone), and their copolymers in vivo. Biomaterials 1981; 2(10)215–220
   PubMedGoogle Scholar
• Schmitt E. A., Flanagan D. R., Linhardt R. J. Degradation and release properties of pellets fabricated from three comercial poly(D,L-lactide-co-glycolide) biodegradable polymers. J. Pharm. Sci 1993; 82(3)326–329
   PubMed Web of Science ®Google Scholar
• Piatt C. G., Gratzi M. G., Jeffcoat A. R., Zweidinger R., Schindler A. Sustained drug delivery systems. II. Factors affecting release rates from poly(ϵ-caprolactone) and related biodegradable polyesters. J. Pharm. Sci 1979; 68(12)1534–1538
   PubMedGoogle Scholar